Evidence map›Paper›PMID 25574125›Full record

ReviewCancer informatics2014

Overcome support vector machine diagnosis overfitting.

Henry Han, Xiaoqian Jiang

Abstract readReview
In one paragraph

Review in Cancer informatics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Morphological Species Delimitation in The Western Pond Turtle (Integrative organismal biology (Oxford, England) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Artificial intelligence and spine imaging: limitations, regulatory issues and future direction.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Henry HanDepartment of Computer and Information Science, Fordham University, New York, NY, USA. ; Quantitative Proteomics Center, Columbia University, New York, NY, USA.
Xiaoqian JiangDivision of Biomedical Informatics, University of California, San Diego, CA, USA.

Funding

iDASH: Integrating Data for Analysis, Anonymization, and SharingU54HL108460 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OHNO-MACHADO, LUCILA · 2010 to 2015
$19.1M
Protection of Records: Privacy (PReP) Technology for Medical ResearchR00LM011392 · NLM · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JIANG, XIAOQIAN · 2013 to 2015
$650k
NHLBI NIH HHS U54 HL108460NLM NIH HHS R00 LM011392
6 · The paper itself

Abstract

Support vector machines (SVMs) are widely employed in molecular diagnosis of disease for their efficiency and robustness. However, there is no previous research to analyze their overfitting in high-dimensional omics data based disease diagnosis, which is essential to avoid deceptive diagnostic results and enhance clinical decision making. In this work, we comprehensively investigate this problem from both theoretical and practical standpoints to unveil the special characteristics of SVM overfitting. We found that disease diagnosis under an SVM classifier would inevitably encounter overfitting under a Gaussian kernel because of the large data variations generated from high-throughput profiling technologies. Furthermore, we propose a novel sparse-coding kernel approach to overcome SVM overfitting in disease diagnosis. Unlike traditional ad-hoc parametric tuning approaches, it not only robustly conquers the overfitting problem, but also achieves good diagnostic accuracy. To our knowledge, it is the first rigorous method proposed to overcome SVM overfitting. Finally, we propose a novel biomarker discovery algorithm: Gene-Switch-Marker (GSM) to capture meaningful biomarkers by taking advantage of SVM overfitting on single genes.

Indexed as

biomarker discoveryoverfittingSVM

Identifiers

PMID25574125
PMCPMC4264614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.